Khorram Avid PhD is categorized under Specialized Medical Practitioners, Except Internal in Encinitas, CA and active since 2006.
Khorram Avid PhD was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Specialized Medical Practitioners, Except Internal business, which does work in the B2C market, and is classified as a Specialized Medical Practitioners, Except Internal, under code number 6213993 by the NAICS.
If you are seeking more information, feel free to contact Avid Khorram at the company’s single location by writing to 701 Garden View Court, Encinitas, California CA 92024 or by phoning (760) 635-0044. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Khorram Avid PhD |
Contact Person: | Avid Khorram |
Address: | 701 Garden View Court, Encinitas, California 92024 |
Phone Number: | (760) 635-0044 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Specialized Medical Practitioners, Except Internal |
SIC Code: | 8011 |
NAICS Code: | 6213993 |
Share This Business: |
Khorram Avid PhD was started in 2006 to provide professional Specialized Medical Practitioners, Except Internal under the SIC code 8011 and NAICS code 6213993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Avid Khorram for inquiries that concern Khorram Avid PhD by calling the company number (760) 635-0044, as your correspondence is most welcome. Additionally, the physical location of the single location of Khorram Avid PhD can be found at the coordinates 33.05904,-117.26056 as well as the street address 701 Garden View Court in Encinitas, California 92024.
For its online presence, you may visit Khorram Avid PhD’s website at and engage with its social media outlets through on Twitter and on Facebook.